NCT01105091View on ClinicalTrials.gov

Epoprostenol for Injection in Pulmonary Arterial Hypertension

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

May 31, 2011

Study Completion Date

July 31, 2011

Conditions
Pulmonary Arterial Hypertension
Interventions
DRUG

ACT-385781A (Actelion Epoprostenol)

per Prescribing Information

DRUG

Flolan®

Per Prescribing Information

Sponsors

Lead Sponsor

Actelion
All Listed Sponsors
lead

Actelion

INDUSTRY